MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-14-2026
Country |
 USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
1.61 M |
Market Cap[1] |
$ 37.8 M |
EBITDA (LTM) |
$ -6.17 M |
P/E (LTM) |
-20.43 |
P/S (LTM) |
1.91 |
EPS (LTM) |
-1.4 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Agilent Technologies
A
|
$ 115.84 | 0.68 % | $ 35.2 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 133.97 | -0.22 % | $ 6.26 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 7.3 | -19.87 % | $ 9.71 M | Nasdaq Capital Market | USA |
 |
Castle Biosciences
CSTL
|
$ 21.26 | 7.97 % | $ 616 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 17.9 | 1.3 % | $ 551 M | Nasdaq Global Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 127.51 | 6.39 % | $ 16 B | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
CareDx, Inc
CDNA
|
$ 22.16 | 2.88 % | $ 1.18 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Interpace Biosciences
IDXG
|
$ 1.8 | - | $ 7.96 M | Nasdaq Global Select Market | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 118.45 | 4.04 % | $ 9.77 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Illumina
ILMN
|
$ 150.17 | 3.41 % | $ 23.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Lantheus Holdings
LNTH
|
$ 99.09 | -0.97 % | $ 6.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 093.84 | -0.68 % | $ 22.5 B | NYSE,SPB |  Schweiz |
 |
Charles River Laboratories International
CRL
|
$ 164.49 | 4.95 % | $ 8.15 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 9.57 | 3.24 % | $ 1.23 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Medpace Holdings
MEDP
|
$ 428.0 | -0.26 % | $ 12.3 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 19.13 | 0.47 % | $ 428 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 203.11 | 1.1 % | $ 20 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 3.94 | 2.34 % | $ 365 M | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 9.49 | 6.15 % | $ 847 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.6 | -1.26 % | $ 25.2 B | NYSE |  Niderland |
 |
Senseonics Holdings
SENS
|
$ 6.32 | -1.71 % | $ 264 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 64.17 | -1.08 % | $ 3.84 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.46 | -0.61 % | $ 5.65 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 258.25 | -0.08 % | $ 21.5 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 456.21 | 1.79 % | $ 172 B | NYSE,SPB | USA |
 |
Waters Corporation
WAT
|
$ 342.18 | 1.05 % | $ 20.4 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.68 | 5.04 % | $ 244 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 9.2 | 0.66 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 193.99 | 0.58 % | $ 21.5 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.